-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Merrimack Pharmaceuticals Inc quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q1 2011 to Q1 2024.
- Merrimack Pharmaceuticals Inc Weighted Average Number of Shares Outstanding, Diluted for the quarter ending March 31, 2024 was 14.5M shares, a 1.4% increase year-over-year.
- Merrimack Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 14.3M shares, a 5.73% increase from 2022.
- Merrimack Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 13.5M shares, a 0.87% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)